Page last updated: 2024-08-23

fosinopril and Obesity

fosinopril has been researched along with Obesity in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashcheulova, T; Demydenko, G; Gerasimchuk, N; Kochubiei, O; Rezunenko, Y1
Drozd, VIu; Haĭdychuk, VS; Khukhlina, OS; Kosar, LIu; Mandryk, OIe1
Gapon, LI; Pliusnin, AV; Popova, SN; Veber, EE; Vershinina, AM1
Galimany, R; Higueruelo, S; Pastor, C; Romero, R; Vaquero, M1
Aguilar-Salinas, CA; Arellano, SA; Gómez-Pérez, FJ; Guillén-Pineda, LE; Magos, GA; Rodriguez, R; Villanueva-Sanchez, O1

Trials

1 trial(s) available for fosinopril and Obesity

ArticleYear
[Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia].
    Terapevticheskii arkhiv, 2005, Volume: 77, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Drug Administration Schedule; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension; Male; Metoprolol; Middle Aged; Obesity

2005

Other Studies

4 other study(ies) available for fosinopril and Obesity

ArticleYear
PATHOGENETIC ADVANCES OF FOSINOPRIL SODIUM WITH HYDROCHLOROTHIAZIDE IN OBESE HYPERTENSIVE PATIENTS.
    Georgian medical news, 2017, Issue:271

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Case-Control Studies; Dinoprost; Diuretics; Drug Therapy, Combination; Endothelium, Vascular; Essential Hypertension; Female; Fosinopril; Humans; Hydrochlorothiazide; Male; Middle Aged; Nitric Oxide Synthase Type II; Obesity; Overweight; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha

2017
[The use of complex tools ezetimibe, hepadyfu fosinopril and correction of blood pressure and endothelial dysfunction in patients with nonalcoholic steatohepatitis and essential hypertension stage II].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2014, Volume: 67, Issue:2 Pt 2

    Topics: Adenine; Anticholesteremic Agents; Azetidines; Carnitine; Drug Combinations; Endothelium, Vascular; Essential Hypertension; Ezetimibe; Fosinopril; Humans; Hypertension; Non-alcoholic Fatty Liver Disease; Obesity; Vascular Diseases

2014
Fosinopril ameliorates exogenous cholesterol-induced incipient glomerular lesions in obese Zucker rats. Effects on eicosanoid secretion.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cholesterol; Cholesterol, Dietary; Eicosanoids; Fosinopril; Kidney Glomerulus; Obesity; Proteinuria; Rats; Rats, Zucker

1998
Effects of omapatrilat on blood pressure and insulin sensitivity in an animal model of insulin resistance.
    Blood pressure, 2001, Volume: 10, Issue:3

    Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Double-Blind Method; Fosinopril; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Models, Animal; Obesity; Pyridines; Rats; Rats, Zucker; Thiazepines; Triglycerides

2001